MedTrace Logo

Combined Therapy in Radiation Proctopathy

NCT01613534 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2012-06-07

No results posted yet for this study

Summary

The aim of this study was to compare the efficacy and safety of two treatment regimens: argon plasma coagulation (APC) alone and APC in combination with sucralfate administered for chronic hemorrhagic radiation proctopathy.

Conditions

  • Chronic Radiation Proctitis

Interventions

DRUG

Sucralfate

Argon plasma coagulation treatment followed by oral sucralfate (6 grams b.i.d.) for four weeks

DRUG

Placebo

Argon plasma coagulation treatment followed by placebo administration for four weeks

Sponsors & Collaborators

  • Medical Centre for Postgraduate Education

    collaborator UNKNOWN

  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Principal Investigators

  • Magdalena R Chruscielewska-Kiliszek, MD, PhD · Medical Centre for Postgraduate Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01613534 on ClinicalTrials.gov